Working with embryos of the African clawed frog, Xenopus, a long-standing model system for developmental biology, the researchers discovered that local flows of ectodermal tissue serve as a directional cue that polarizes embryonic myeloid cells, the earliest immune cells to arise in vertebrate development, and guides their migration across the embryonic surface. The finding, rooted in live imaging of intact embryos, suggests that physical movement of the tissue itself can act as a compass for patrolling immune cells, a concept that substantially broadens how scientists think about cell guidance during development.

For decades, the dominant framework for understanding directed cell migration has been chemotaxis, in which cells detect spatial gradients of diffusing signaling molecules and reorganize their internal machinery to move toward or away from the source. In immune surveillance, chemoattractants released at sites of injury or infection recruit myeloid cells with remarkable precision. But chemotaxis has never been the whole story. Cells also respond to the stiffness of their surroundings, to adhesive patterns laid down in the extracellular matrix and to mechanical forces transmitted through neighboring cells. The new study adds a striking item to this list of physical guidance mechanisms: the bulk flow of the tissue in which the cells are embedded.

During morphogenesis, sheets of embryonic cells do not sit still. They intercalate, converge, extend and stream past one another as the body plan takes shape, generating large-scale tissue flows that reshape the embryo. Le and colleagues found that these flows, far from being mere background motion, actively inform immune cell behavior. Myeloid cells residing in or on the flowing ectoderm aligned their polarity with the direction of local tissue movement, extending their leading edge downstream of the flow and committing to persistent, directional migration along the current of cells.

The technical achievement behind this discovery lies in the combination of live embryonic imaging with quantitative analysis of both cell trajectories and tissue velocity fields. By tracking individual myeloid cells at high spatial and temporal resolution while simultaneously mapping the displacements of the surrounding ectodermal cells, the researchers could correlate immune cell orientation and migration direction with the local flow vector of the tissue. The statistical coupling between flow and migration was strong and consistent, indicating that the cells were genuinely reading mechanical information from their moving environment rather than drifting passively or following unrelated chemical gradients.

Crucially, the mechanism operates through cell-on-cell interactions. As the ectodermal cells stream past, they exert forces on, and exchange adhesive contacts with, the myeloid cells in their midst. These mechanical and adhesive interactions appear to bias the internal cytoskeletal polarity of the immune cell, coordinating the actin dynamics that drive protrusion at the cell front and contraction at the rear. In other words, the flowing tissue does not carry the immune cells like debris in a river; it actively instructs them, polarizing their intracellular machinery so that they migrate directionally in response to the motion they experience.

This mode of guidance is conceptually distinct from chemotaxis in an important way. A chemical gradient provides positional information through the concentration of a molecule in space, whereas a tissue flow provides information through movement in time. An immune cell embedded in a flowing sheet effectively samples the relative motion of its substrate across its own surface, converting a dynamic mechanical field into an intracellular polarity axis. Such a mechanism has the advantage of being self-organizing: wherever morphogenetic flows occur, guidance comes for free, without the need for pre-patterned chemoattractant sources.

The implications reach well beyond Xenopus. Morphogenetic tissue flows are a universal feature of animal development, driving gastrulation, neurulation and organ formation across species. If migrating cells generally couple their polarity to such flows, then the same guidance principle could steer a wide range of cell types, from neural crest cells that populate the face to primordial germ cells that journey to the gonad, and it could operate in mammalian embryos as well. The finding also suggests a way in which immune surveillance might be automatically coordinated with tissue construction, since the very movements that build the embryo would simultaneously distribute its patrolling immune cells to where they are needed.

There are also implications for regenerative medicine and immunology. Wound healing, inflammation and fibrosis all involve both immune cell migration and tissue remodeling, and the new work suggests these processes may be mechanically intertwined in ways not previously appreciated. If tissue motion can direct immune cells, then therapies or engineered tissues might one day be designed to steer immune responses by controlling the mechanical environment, guiding anti-inflammatory cells into damaged tissue or redirecting cells away from sites where their accumulation causes harm.

Many questions remain. The molecular machinery that translates tissue flow into intracellular polarity, likely involving mechanosensitive adhesion receptors and cytoskeletal regulators, has yet to be fully identified. Whether the same mechanism functions in later developmental stages, in adult tissues or during disease remains to be tested. But the core message of the study is already clear and, for many in the field, eye-opening: developing tissues do not merely tolerate the immune cells traveling through them. They actively carry information, and the flowing fabric of the embryo itself helps guide the sentries of the immune system to their destinations.

Subject of Research: Mechanical guidance of embryonic myeloid cell migration by local tissue flow

Article Title: Tissue flow acts as a guidance cue for immune cell polarization and directional migration

Article References: Le, H. A., Hartmann, J., Alert, R., & Mayor, R. (2026). Tissue flow acts as a guidance cue for immune cell polarization and directional migration. Nature Cell Biology. https://doi.org/10.1038/s41556-026-02058-9

Image Credits: AI Generated

DOI: 10.1038/s41556-026-02058-9

Keywords: tissue flow, immune cells, cell migration, cell polarization, Xenopus embryos, myeloid cells, ectoderm, mechanotransduction, developmental biology, chemotaxis, cell-on-cell interactions, Tissue

Rett syndrome predominantly affects young girls and typically manifests between two and three years of age, a critical developmental window for cerebral vascularization. The study, recently published in Molecular Psychiatry, encapsulates a detailed exploration of how mutations R306C and R168X in MECP2 result in similar downstream vascular defects, despite their distinct genetic nature. This convergence on miRNA-126-3p overexpression positions vascular dysfunction as a previously underappreciated hallmark in Rett pathology, offering novel insights into the disease’s complex neurobiology.

To dissect the vascular anomalies driven by Rett mutations, the MIT team, led by Research Scientist Tatsuya Osaki and senior investigator Mriganka Sur, utilized state-of-the-art tissue engineering to construct three-dimensional microvascular networks. These networks were generated from human induced pluripotent stem cells (iPSCs) derived from patients harboring the Rett mutations. The iPSCs differentiated into endothelial cells, the key cellular constituents of blood vessels, which self-organized within a gel scaffold, incorporating fibroblasts to mimic the in vivo microenvironment. This microphysiological system was equipped with microfluidic circulation to simulate bloodstream dynamics, allowing precise functional and molecular analyses.

Comparative studies between the Rett mutant cultures and their CRISPR-engineered isogenic controls revealed a marked deficiency in the expression and junctional localization of zonula occludens-1 (ZO-1), a pivotal tight junction protein. ZO-1 functions analogously to connective grout, sealing intercellular gaps to preserve vessel impermeability. The downregulation of ZO-1 was a unifying feature for both R306C and R168X mutations, providing tangible evidence of barrier compromise. Functional assays demonstrated increased leakage across the mutated endothelial networks, underscoring the dysfunction of the blood-brain barrier within the Rett context.

The investigation extended to a more complex ex vivo model incorporating astrocytes, critical components of the neurovascular unit that support blood-brain barrier properties. Even within these enhanced co-cultures, endothelial cells carrying the Rett mutations exhibited compromised barrier function. This finding aligns with a growing consensus that blood-brain barrier disruption contributes not only to Rett syndrome’s neurological deficits but also to other neurodegenerative conditions such as Alzheimer’s, Huntington’s, ALS, and frontotemporal dementia.

Delving into the mechanistic underpinnings, the MIT scientists focused on the paradox where MECP2 repression loss did not directly explain the decrease in ZO-1. Since microRNAs are potent post-transcriptional regulators capable of silencing gene expression, they hypothesized that an intermediary miRNA might bridge this gap. Subsequent miRNA profiling and RNA sequencing unequivocally identified miRNA-126-3p as significantly overexpressed in Rett mutant endothelial cells.

To corroborate the causal role of miRNA-126-3p, the researchers applied antisense oligonucleotides specifically designed to reduce its expression in the mutant cultures. This intervention robustly restored ZO-1 levels and substantially improved endothelial barrier integrity, validating the link between miRNA-126-3p dysregulation and vascular leakiness. Restoration of other vascular-related molecular pathways further supported the therapeutic potential of targeting this miRNA axis.

An intriguing translational angle emerges from the availability of miRisten, a pharmacological inhibitor of miRNA-126, currently undergoing clinical trials for leukemia treatment. The MIT group plans to test miRisten in murine models of Rett syndrome to evaluate its efficacy in rescuing vascular and neurological deficits in vivo. Should these trials prove successful, miRNA-126 inhibitors could represent a transformative therapeutic strategy that addresses a fundamental component of Rett syndrome pathology.

This research signifies a paradigm shift in understanding Rett syndrome by positioning vascular dysfunction and microRNA misregulation at the heart of its neurodevelopmental defects. These insights open up promising avenues for therapeutic development beyond the conventional focus on neuronal pathology alone. The identification of vascular compromise also suggests that similar mechanisms might be relevant in other neurological disorders marked by blood-brain barrier breakdown.

The integration of advanced tissue engineering and molecular biology in this study underscores the potential of interdisciplinary approaches to unravel complex disease mechanisms. By harnessing patient-derived stem cells and bioengineered vascular systems, the team achieved an unprecedented window into the microvascular biology of Rett syndrome, setting a new standard for neurovascular research in genetic disorders.

Looking forward, this research not only illuminates pathogenic pathways in Rett syndrome but also elevates the importance of endothelial cell function and intercellular communication in neurodevelopmental health. As the scientific community seeks more effective treatments for Rett and related disorders, targeting microRNA axes may offer a powerful, nuanced strategy to restore vascular and neuronal homeostasis.

The promising findings by Osaki, Sur, and colleagues exemplify the rapid progress in the field of neurogenetics and vascular biology, highlighting the intricate interplay between genetic mutations and microenvironmental factors in brain function. This study marks a major advancement towards unmasking the full spectrum of Rett syndrome’s molecular pathology and offers hope for innovative therapies that may one day improve outcomes for affected individuals.

Subject of Research: Human tissue samples

Article Title: miR126-mediated alteration of vascular integrity in Rett syndrome

News Publication Date: 18-Feb-2026

Web References: DOI: 10.1038/s41380-026-03492-9

Image Credits: Tatsuya Osaki/MIT Picower Institute

Keywords: Neuroscience, Rett syndrome, Neurological disorders, Molecular biology, RNA, MicroRNA, Blood vessels